GlassScriptPhysician profile
Maria T Reyes
NPI 1467526558
$4,402.82
in general payments reported to CMS, 2019-2025
24 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $706 · 2021: $794 · 2022: $844 · 2023: $403 · 2024: $418 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004 · Entertainment: $13.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.32 |
| Entertainment | $13.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $691.45 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $635.13 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $595.11 | 2019-2024 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.98 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $476.82 | 2019-2024 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $289.03 | 2019-2023 | Steglatro |
| Sanofi-Aventis U.S. LLC | $262.60 | 2019-2021 | |
| Abbott Laboratories | $228.35 | 2020-2023 | Freestyle Libre 3 |
| Pfizer INC. | $149.12 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.71 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $67.16 | 2019-2022 | |
| Abbvie INC. | $67.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $47.40 | 2019-2020 | |
| Astellas Pharma US INC | $44.13 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $42.52 | 2022-2023 | Optimizer |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $37.71 | 2020 | |
| Amgen INC. | $27.81 | 2019 | |
| Nevro Corp. | $27.19 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.59 | 2020-2021 | |
| Boston Scientific Corporation | $18.12 | 2022 | |
| Janssen Biotech, INC. | $17.03 | 2019 | |
| Exact Sciences Corporation | $15.10 | 2024 | Cologuard Collection Kit |
| Optos, INC. | $13.88 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Amarin Pharma, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.